DIFF Biotech to Speak at ACCESS ASIA Partnering Forum | Online Showcase

September 25, 2025 (9:30 AM CST) — We’re pleased to announce that Saidan Lei, Director, Business Development of DIFF Biotech, will present at the ACCESS Asia Partnering Forum Online Showcase. ACCESS Asia builds on the success of ACCESS China, expanding Asia’s leading cross-border biotech platform to connect innovators with global pharma, investors, and partners

About DIFF Biotech

DIFF Biotech is a biotechnology company leveraging proprietary recombinant virus technology to develop innovative solutions across vaccines, oncology, gene therapy, and antiviral drug development. Its pipeline spans both human and animal health, including DIFF-DIVA H9 (DIVA-capable inactivated avian influenza vaccine), DIFF-H9N2 (first-in-class live attenuated avian influenza vaccine), DIFF-Rab (VSV-vectored rabies vaccine for companion animals), and DIFF-flu (freeze-dried trivalent intranasal influenza vaccine for humans). With more than 70 patent applications, including multiple international PCTs, DIFF Biotech is advancing safe, effective, and scalable viral-based products to address pressing global health challenges.

About the speaker

Ms. Saidan Lei brings over ten years of extensive experience in the biopharmaceutical industry, with demonstrated expertise in international business development and project management. She has actively participated in and led multiple License-in and License-out initiatives, overseeing key activities including regulatory submissions, project transformation, alliance management, and the execution of licensing agreements.

About ACCESS ASIA Partnering Forum

ACCESS Asia Partnering Forum Online Showcase is scheduled to be held on September 25, 2025, 9:30 AM (China Standard Time) via Zoom.
This event will spotlight the 1st wave of 100 innovators, providing them with a global stage to showcase pipelines and connect with pharma, investors, and strategic partners worldwide.

Conference Name: ACCESS Asia Partnering Forum Online Showcase
Date & Time: September 25, 2025, 9:30 AM (China Standard Time)
View more information at: https://biotochina.org/